Why the study?
Do different commercial heparin preparations vary in their ability to induce aggregation of human platelets?
Do different commercial heparin preparations vary in their ability to induce aggregation of human platelets?
Commercial heparin preparations vary considerably in their ability to induce platelet aggregation in vitro.
No takes yet. Share an insight, caveat, or question.
Different heparin brands may differ in platelet effects; hypothesis-generating in vitro data leaves open clinical implications.
C. Eika (1972) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: